'Digital Pill' Lets Doctors Know It's Been Taken
The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or "mixed" episodes for people with bipolar disorder.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Abilify | Bipolar | Depression | Food and Drug Administration (FDA) | Health | Mania | Schizophrenia